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Abstract 
A 19-year-old man developed rapidly progressive muscle weakness and dysesthesia in 
the extremities, and dyspnea after a flu-like episode. Nerve conduction studies showed 
reduced motor nerve conduction velocities with conduction block, and sensory nerve 
action potentials could not be evoked. The patient was diagnosed as having Guillain-
Barré syndrome (GBS), and was treated with 2 cycles of intravenous immunoglobulin 
(IVIg) therapy and was assisted by mechanical ventilation. During the recovery course of 
the illness, he experienced several attacks of psychomotor agitation from the 37th 
hospital day, and generalized tonic convulsive seizures suddenly developed on the 42nd 
hospital day. Brain MRI showed high-intensity lesions in the bilateral thalamus and 
medial temporal lobes. The convulsions were controlled by continuous thiopental 
infusion (until the 50th hospital day) and mechanical ventilation (until the 84th hospital 
day). Intravenous methylprednisolone pulse therapy (1,000 mg/day) for 3 days followed 
by dexamethasone (16 mg/day) was added. After relief of convulsive seizures, prominent 
orolingual dyskinesia appeared, and on MRI marked atrophy of the bilateral medial 
temporal lobes was seen. Anti-N-methyl-D-aspartate receptor (NMDAR) antibodies in 
serum and cerebrospinal fluid were positive on the 92nd hospital day. Anti-NMDAR 
encephalitis usually affects young females but a small number of male cases with this 
disease have been reported. Our male patient was unique in having GBS, a post-
infectious autoimmune disease, as a preceding disease, suggesting that anti-NMDAR 
encephalitis itself is caused by a parainfectious autoimmune mechanism.  
Case Rep Neurol 2011;3:7–13 
DOI: 10.1159/000323751 
Published online: 
January 11, 2011 
© 2011 S. Karger AG, Basel 
ISSN 1662–680X 
www.karger.com/crn 
 
 
8
Introduction 
Recently, a unique limbic encephalitis that predominantly affects young females and 
shows various manifestations, including initial psychosis, and subsequent central 
hypoventilation, intractable seizures, dysautonomia and prominent orofacial dyskinesia, 
has been noted [1, 2]. In patients with this disorder a new anti-neural antibody for the 
NR1/NR2 heteromers of the N-methyl-D-aspartate receptor (NMDAR) has been 
identified as a disease-specific hallmark [3], recently adding that the NR1 is possibly a 
main epitope [2]. Thus, this disorder is now called anti-NMDAR encephalitis. Although it 
is now widely accepted that the presence of ovarian teratoma is an important 
predisposing factor for the development of anti-NMDAR encephalitis [4, 5], the 
mechanisms that initiate the disease are still incompletely understood. 
We here report on a young male patient with anti-NMDAR encephalitis which 
developed during the recovery course of severe Guillain-Barré syndrome (GBS), and 
propose that a post-infectious autoimmune mechanism may play an important role in the 
pathogenesis of anti-NMDAR encephalitis. 
Case Report 
A 19-year-old man with no history of systemic disease was hospitalized due to muscle weakness and 
dysesthesia in the extremities following cough and nasal discharge 2 weeks earlier. Neurological 
examination showed muscle weakness and sensory disturbance in the distal parts of the extremities, and 
all deep tendon reflexes were absent. Cerebrospinal fluid (CSF) at 5 days after onset of weakness 
contained a normal cell count, but the concentration of total protein was elevated (52.8 mg/dl). The 
patient was diagnosed as having GBS and treated with intravenous immunoglobulin (IVIg) therapy (0.4 
g/kg/day) for 5 days. However, the symptoms worsened gradually, he was not able to raise his upper 
limbs and to walk from the 5th hospital day. Furthermore, dysarthria, dysphagia, and dyspnea appeared 
gradually from the 9th hospital day. He was transferred to our hospital on the 12th hospital day. On the 
day of transfer, nerve conduction studies showed reduced motor nerve conduction velocities (right 
median nerve: 11.3 m/s, normal value >55 m/s, right tibial nerve: 36.6 m/s, normal value >45 m/s) with 
conduction block (fig. 1), and sensory nerve action potentials could not be evoked in both nerves. The 
F-wave of the right tibial nerve was not evoked. There was neither anti-GM1 IgG antibody nor anti-
GQ1b IgG antibody in the serum. Although mechanical ventilation was necessary from the day of 
transfer, muscle weakness in the extremities and respiratory function gradually improved after the 
second course of IVIg therapy from the 22nd hospital day for 3 days, and the patient was trained for 
weaning from mechanical ventilation. However, he started to experience occasional psychomotor 
agitation from the 37th hospital day, and generalized tonic convulsive seizures suddenly developed 
following paralytic ileus and tachycardia on the 42nd hospital day. Since the convulsive seizures did not 
respond to intravenous administration of diazepam, phenytoin, or midazolam, continuous thiopental 
infusion was used and mechanical ventilation was continued. CSF showed a slightly increased cell count 
(8/μl, mononuclear cells 7), a highly elevated level of total protein (446 mg/dl), and normal glucose 
concentration. Brain MRI showed high-intensity lesions in the bilateral thalamus and medial temporal 
lobes on diffusion and FLAIR images (fig. 2a), and the electroencephalogram showed diffuse spike and 
wave complexes. He was diagnosed as having some type of autoimmune encephalitis, and intravenous 
methylprednisolone pulse therapy (1,000 mg/day) for 3 days followed by dexamethasone (16 mg/day) 
was administered, and used until the 70th hospital day with a gradual dose reduction. Although the 
generalized convulsive seizures disappeared and the infusion of thiopental was ceased on the 52nd 
hospital day, orolingual dyskinesia gradually developed. On the brain MRI on the 64th hospital day, the 
abnormal high-intensity lesions in the bilateral thalamus were reduced, while marked atrophy of the 
bilateral medial temporal lobes was seen (fig. 2b). Respiratory failure and autonomic dysfunction that 
included disturbed bowel movement and abnormal cardiovascular responses gradually improved, and 
he was released from mechanical ventilation on the 84th hospital day. However, the patient remained 
unresponsive to verbal commands and severe orolingual dyskinesia persisted until he was transferred to 
a local hospital on the 193rd hospital day.  
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During investigation of the causes of the encephalitis, there were no laboratory data suggesting viral 
encephalitis, including herpes simplex, influenza, varicella zoster, cytomegalovirus, measles, and human 
herpes virus-6. Urological examination was normal and no detectable neoplasm was seen on either chest 
or abdominal CT. Two years after the onset of seizures, his condition was very similar to when he was 
discharged from our hospital, and repeated examinations showed no appearance of a tumor. 
Immunochemical Analysis of Anti-NMDAR Antibody in Serum and CSF 
Detection of anti-NMDAR antibody on the same samples was carried out as follows [6]: cDNA 
encoding NR1 and NR2B was ligated into the expression vectors and transfected into human embryonic 
kidney (HEK) 293 cells in the media containing 10 μM MK-801 using Lipofectamine (Invitrogen). 
Twelve hours after transfection, HEK-293 cells were fixed in 4% paraformaldehyde in 0.1 M phosphate-
buffered saline (PBS, pH 7.4) for 20 min. After non-specific binding was blocked with 10% goat serum 
in PBS, these cells were incubated with patient sera (1:40) or CSF (1:2) overnight at 4°C and then with 
FITC-conjugated rabbit anti-human IgG (BD Biosciences) for 30 min at room temperature. SlowFade 
gold anti-fade reagent (Molecular Probes) was applied to the slides and the staining was observed under 
a fluorescence microscope.  
Both serum and CSF obtained from the 92nd hospital day specifically reacted with HEK-293 cells 
expressing heteromers of NR1/NR2B (fig. 3). 
Discussion 
In our case, encephalitis was shown by abnormal intensity of the bilateral thalamus and 
medial temporal lobes on brain MRI at an early stage. However, the former thalamic 
lesions seemed to be edema due to status epilepticus, and the main lesion of this 
encephalitis was assumed to be in the bilateral medial temporal lobes, because the 
thalamic lesions rapidly resolved after treatment, whereas the bilateral medial temporal 
lobes showed progressive atrophy. Moreover, his clinical manifestations consisted of 
psychiatric symptoms, intractable seizures, dysautonomia and involuntary movements, 
and anti-NMDAR antibody was demonstrated in both serum and CSF. He was finally 
diagnosed as having anti-NMDAR encephalitis. 
Anti-NMDAR encephalitis usually affects young females, and an early series of 
patients with this disease was found to have a high association of ovarian teratoma [3, 4]. 
Thus, the pathogenetic significance of ovarian teratoma in this encephalitis was 
investigated and it was proposed that, since the ovarian teratomas obtained from diseased 
patients showed mature- and immature-appearing neurons with expression of NR2B 
and/or NR2A [3, 4], ectopically expressed NMDARs in ovarian teratoma contribute to the 
production of antibodies to NMDARs [3]. Thus, early removal of ovarian teratoma has 
been recommended for patients with this disease [7]. However, a recent study on a large 
number of patients with anti-NMDAR encephalitis has shown that this ovarian tumor 
could not be found in about 40 to 80% of adult patients with the disease [1, 2, 8], although 
careful follow-up examinations on the detection of tumors are always required in these 
patients. Increased recognition of this unique encephalitis has also disclosed that children 
and adolescents also encounter it [9, 10], although the frequency of associated ovarian 
teratoma was much lower in children than adults. Additionally, a small number of male 
cases
 with anti-NMDAR encephalitis [11] were reported, indicating that other causes 
besides ovarian teratoma can produce encephalitis.  
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In the pathogenesis of anti-NMDAR encephalitis, the antibody immune response has 
been shown to be more relevant than cytotoxic T-cell mechanisms [12] and the vast 
majority of patients with this type of disease have a history of prodromal flu-like 
symptoms. It was, therefore, suggested that the preceding flu-like illness leads to the 
triggering of abnormal antibody production targeting NMDARs [12]. In this situation the 
presence of ovarian teratoma with a high expression of NMDAR epitopes may predispose 
or exaggerate the production of anti-NMDAR antibodies; these NMDAR antibodies then 
cause a specific, titer-dependent, and reversible decrease in NMDAR surface density and 
synaptic localization, especially in the hippocampus [13], resulting in learning, memory, 
and other behavioral deficits seen in patients with anti-NMDAR-encephalitis. Thus, this 
encephalitis seems to be causally related to a parainfectious autoimmune mechanism. 
Immunosuppressive therapy, including corticosteroid, plasma exchange and IVIg, has 
been used for the treatment of this disease [1]. Recently, rituximab, an anti-CD20 
monoclonal antibody, is expected to accelerate the recovery of patients with this type of 
disease
 [14]. 
Our young male patient with anti-NMDAR encephalitis lacked testicular or 
mediastinal teratoma, which was previously reported to be of paraneoplastic origin [11]. 
On the other hand, his clinical course was characterized by a preceding attack of GBS: this 
disease is a representative post-infectious peripheral demyelinating neuropathy with 
underlying autoimmune abnormalities [15]. Although a causative relationship between 
GBS and anti-NMDAR encephalitis has not been studied, it is likely that GBS-related 
abnormal immune reactions secondarily caused another autoimmune state with anti-
NMDAR encephalitis. Although serial examinations of anti-NMDAR antibodies in both 
serum and CSF might be useful in clarifying the underlying immune condition of this 
patient, there were no available samples. This case report has provided the clinical 
evidence that a parainfectious autoimmune reaction is an important pathogenetic 
mechanism in the development of anti-NMDAR encephalitis. 
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Fig. 1. Motor nerve conduction study of the right median nerve and the right tibial nerve. a Right 
median nerve on the 12th hospital day. b Right tibial nerve on the 12th hospital day. These studies 
showed reduced motor nerve conduction velocities (MCV) with conduction block (median nerve 11.3 
m/s, tibial nerve 36.6 m/s). The sizes of the compound muscle action potential of the right median nerve 
were 2.0 mV at the wrist and 0.33 mV at the elbow, and those of the right tibial nerve were 1.0 mV at the 
ankle and 0.57 mV at the popliteal fossa, respectively. c Motor nerve conduction study of the right 
median nerve on the 94th hospital day, showing improvement of the MCV (23.2 m/s) and severity of 
the conduction block (the sizes of the compound muscle action potential were 0.404 mV at the wrist 
and 0.225 mV at the elbow). MCV of right tibial nerve on the 94th day was not evoked. 
 
 
 
Fig. 2. Brain MRI findings. a Images on the 42nd hospital day showed high-intensity lesions in the 
bilateral thalamus and bilateral medial temporal lobes. b Images on the 64th hospital day revealed 
improved abnormal high-intensity lesions in the bilateral thalamus but progressive atrophy of the 
bilateral medial temporal lobes. 
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Fig. 3. Immunohistochemical demonstration of antibodies against NMDAR. a CSF of the patient 
showing positive immunoreactivity against heteromers of NR1 and NR2B subunits of NMDAR. b Anti-
rabbit IgG showing positive immunoreactivity against NR1 subunit of NMDAR. c Merge image. Arrows 
indicate positively stained HEK cells. Immunofluorescence staining (×200). 
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